Undervalued Stock After Earnings
Added 2021-02-11 23:54:52 +0000 UTCHey Patreons,
I want you to take a look at a company by the name of DexCom (NASDAQ: DXCM). For diabetic patients its a household name. They make some of the leading CGM systems in the world. Currently (February 12, 2020) the price of the share is at $392 and I am working on a full video showing why the price should be $520-$540, a gap that I see closing within the next year. The company is growing nicely with phenomenal margins and leading technology and brand recognition, so for me that would be a great opportunity to invest in a 40 billion dolar company with a lot of upside.
As always, this is NOT financial advice, be careful and make sure you research this before investing. This is just my opinion, do your own research please and let me know your thoughts.
Comments
«П...дец ох...шая компания» - буду брать 😁
Anton Pleshakov
2021-02-13 18:56:48 +0000 UTCApple and Samsung are rumored to be releasing their next gen watches with the CGM feature built in. How do you see that competition affecting the valuation of this company?
Michael Fischer
2021-02-13 16:02:11 +0000 UTCPerfect timing, bought in the morning at the bottom. 387
Tom Deschenes
2021-02-13 02:32:43 +0000 UTCTom this is great work bringing DexCom to our attention. Would be really amazing if you could also look at rising star $SENS and compare/contrast them
k c
2021-02-13 02:23:27 +0000 UTCNot yet
Generico Fakero
2021-02-12 22:44:01 +0000 UTChttps://pubmed.ncbi.nlm.nih.gov/32453604/ @Toolfriend, please share insight how Senseonics is truly disruptive? We can all benefit from it. There are other clinical comparison in addition to this one pasted above and these outcome differences are not a drastic step-changer where the market will just flip from the incumbent to this one. And from my past interaction with Dexcom, it’s a giant in this segment with strong commercial presence and good reputation physicians. Not suggesting Senseonics can’t compete just that I can’t find anything THAT unique about them thus far.
Mike Lin
2021-02-12 12:14:59 +0000 UTCHello Tom please check this bevor you make the astonishing video This technology is disruptive Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe.
Toolfriend
2021-02-12 09:05:16 +0000 UTCWill the Real Larry, please stand up!
Tom Deschenes
2021-02-12 08:27:43 +0000 UTCI use TD Ameritrade. After hours and premarket are about 2-3 hours extra....
Aryn Nakaoka
2021-02-12 06:28:39 +0000 UTCOn which platform can you trade after hours? I am using Trading 212 and I am not allowed to trade after or pre-market. Or maybe I am doing something wrong?
Lyubomir
2021-02-12 06:24:05 +0000 UTCI’ve been using Dexcom for years. The G6 is why it’s up right now because of integration with Tandem pumps and it’s the only CGM FDA approved for testing and decision making, also the only one approved by Medicare
Daniel Johnson
2021-02-12 02:18:09 +0000 UTCI had Dexcom in stock in the past and I’m also a user (for many years) of their diabetic continuous glucose monitor. I believe most of the upside is gone on this one, $400 is the max. Sorry Tom for not agreeing but I do not think this is a good one for gains in near future. At the nearly $400 price bow, it’s a five year long or better. They look good because of something that happened in the last year or so that will likely not see another repeat to boost vakue
Daniel Johnson
2021-02-12 02:16:07 +0000 UTCI wonder that too
leonardo
2021-02-12 02:06:17 +0000 UTCowned this since it was in the $100s
Andrew Knight
2021-02-12 00:43:43 +0000 UTC$SENS is coming for them!! Please take a look at them Tom!
Andrew Dykes
2021-02-12 00:37:24 +0000 UTCIn at 393.74. Thanks Tom!
Michael Fischer
2021-02-12 00:29:22 +0000 UTCThis company is almost 100% owned institutional, can this be worrying if these institutes decided to shift their money to another company?
yazan
2021-02-12 00:26:47 +0000 UTCThis is excellent financial advice! Thank you Larry!😬
Jeremy Bass
2021-02-12 00:03:52 +0000 UTCWhat about 9/2021 calls @ $500 for $23.30 - is that a good way to play this? Or how about 1/21/2022 ($500 Strike) $35.50? 1/20/2023 $500 Strike is $69.30 ....
Aryn Nakaoka
2021-02-12 00:03:20 +0000 UTCHow about the upcoming competitor SENS?
Anson Cheung
2021-02-12 00:02:15 +0000 UTCAfterhours is presenting a good buying opportunity.
Aryn Nakaoka
2021-02-12 00:01:29 +0000 UTCBro what do you think about hyln
Ahmed Hussain
2021-02-11 23:58:31 +0000 UTCSENS
Gabriel Mishler
2021-02-11 23:58:29 +0000 UTCBig fan of this company. Their product the G6 is pretty incredible. Also some news from today: https://www.investors.com/news/technology/dexcom-stock-dexcom-earnings-q4-2020/
k c
2021-02-11 23:57:26 +0000 UTCDo you have already a position on it?
Swizz Mike
2021-02-11 23:57:10 +0000 UTC
